Revenue: As of FY2026 Q1, the actual value is USD 6.681 M.EPS: As of FY2026 Q1, the actual value is USD -0.21.EBIT: As of FY2026 Q1, the actual value is USD -1.553 M.<h3>Segment Revenue</h3><ul><li>Engineering Design Services: Revenue decreased by 59.3% to $656,101 for the quarter ending September 30, 2025, compared to $1,613,901 in the same period in 2024, primarily due to decreased demand and the transfer of the single-use cystoscope program to Systems Manufacturing.</li><li>Systems Manufacturing: Revenue increased by 297.3% to $4,866,706 for the quarter ending September 30, 2025, from $1,225,178 in the same period in 2024, driven by significant increases in customer demand and scaling of manufacturing capabilities.</li><li>MicroOptics Lab: Revenue decreased by 76.5% to $100,376 for the quarter ending September 30, 2025, from $428,157 in the same period in 2024, due to delays in receiving new production orders from defense customers.</li><li>Ross Optical Industries: Revenue increased by 13.7% to $1,057,640 for the quarter ending September 30, 2025, from $929,817 in the same period in 2024, attributed to customers resuming deliveries previously delayed due to tariffs.</li></ul><h3>Operational Metrics</h3><ul><li>Gross Profit: Decreased to $946,358 for the quarter ending September 30, 2025, from $1,117,330 in the same period in 2024, with gross margin decreasing to 14.2% from 26.6%.</li><li>Net Loss: Increased to -$1,637,030 for the quarter ending September 30, 2025, from -$1,311,247 in the same period in 2024.</li><li>Research and Development Expenses: Decreased to $311,840 for the quarter ending September 30, 2025, from $400,659 in the same period in 2024.</li><li>Selling, General and Administrative Expenses: Increased to $2,229,773 for the quarter ending September 30, 2025, from $1,963,612 in the same period in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Provided by Operating Activities: $78,227 for the quarter ending September 30, 2025, compared to -$318,622 in the same period in 2024.</li><li>Net Cash Used in Investing Activities: -$301,789 for the quarter ending September 30, 2025, compared to -$28,099 in the same period in 2024.</li><li>Net Cash Used in Financing Activities: -$158,068 for the quarter ending September 30, 2025, compared to $577,015 in the same period in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to continue scaling its manufacturing capabilities to meet increased customer demand, particularly in Systems Manufacturing. The focus will be on enhancing production efficiency and expanding market reach in the medical devices and defense/aerospace sectors.</li><li>Non-Core Business: There are no specific plans mentioned for divestitures or emerging segments, but the company is focused on maintaining its current operations and improving financial performance through strategic investments and operational efficiencies.</li></ul>

Precision Optics | 10-Q: FY2026 Q1 Revenue: USD 6.681 M